Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Melanoma 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Myelodysplastic Syndromes 1Medulloblastoma 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 4Taxes 3S 1 (combination) 3130-nm albumin-bound paclitaxel 3toripalimab 2Drug Therapy 2Albumin-Bound Paclitaxel 2surufatinib 1nimotuzumab 1envafolimab 1endostar protein 1conteltinib 1camrelizumab 1apatinib 1Simvastatin 1Radiosurgery 1Nivolumab 1Metformin 1Immunotherapy 1Endostatins 1Digoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Pancreatic Cancer × Digoxin × Clear all
NCT03889795 2025-10-20

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

University of Toledo

Phase 1 Active not recruiting
15 enrolled
GastrointestinalOther solid neoplasm

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡